Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.740
+0.535 (16.69%)
At close: Nov 4, 2024, 4:00 PM
3.690
-0.050 (-1.34%)
After-hours: Nov 4, 2024, 4:47 PM EST

Cardiff Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
174666325263510
Upgrade
Market Cap Growth
51.18%5.71%-75.20%-60.31%6519.33%-20.54%
Upgrade
Enterprise Value
116-13-491216002
Upgrade
Last Close Price
3.741.481.406.0117.991.24
Upgrade
PE Ratio
--1.59-1.57-8.28-16.62-0.44
Upgrade
PS Ratio
251.48135.50162.04702.511736.3139.24
Upgrade
PB Ratio
3.260.950.591.804.961.31
Upgrade
P/FCF Ratio
-3.06-2.10-1.80-10.85-38.45-0.72
Upgrade
P/OCF Ratio
-3.10-2.14-1.85-10.95-38.95-0.72
Upgrade
EV/Sales Ratio
173.86-26.53-126.70338.281640.6610.20
Upgrade
EV/EBITDA Ratio
-0.770.291.23-4.28-32.25-0.15
Upgrade
EV/EBIT Ratio
-0.760.291.23-4.21-31.46-0.15
Upgrade
EV/FCF Ratio
-1.050.411.40-5.22-36.34-0.19
Upgrade
Debt / Equity Ratio
0.040.030.030.020.010.24
Upgrade
Debt / FCF Ratio
-0.06-0.07-0.08-0.13-0.05-0.13
Upgrade
Asset Turnover
0.010.000.000.000.000.02
Upgrade
Quick Ratio
4.857.1913.5821.5521.462.17
Upgrade
Current Ratio
4.977.4114.2522.2821.792.37
Upgrade
Return on Equity (ROE)
-58.80%-47.07%-31.37%-21.07%-28.50%-188.72%
Upgrade
Return on Assets (ROA)
-34.12%-28.69%-18.77%-12.69%-16.14%-76.48%
Upgrade
Return on Capital (ROIC)
-38.95%-31.37%-19.75%-13.23%-17.28%-109.03%
Upgrade
Earnings Yield
-23.48%-62.67%-61.88%-11.22%-3.04%-170.97%
Upgrade
FCF Yield
-18.65%-47.59%-55.68%-9.22%-2.60%-138.90%
Upgrade
Buyback Yield / Dilution
-0.93%-2.47%-11.71%-86.97%-249.44%-156.37%
Upgrade
Total Shareholder Return
-0.93%-2.47%-11.71%-86.97%-249.44%-156.37%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.